Ngā hua rapu kaituhi :: APM

1

The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps mā Claus Bachert, Alexandra Hicks, Simon Gane, Anju T. Peters, Philippe Gevaert, Scott D. Nash, Julie Horowitz, Harry Sacks, Juby A. Jacob‐Nara

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis mā Anju T. Peters, Martin Wagenmann, Jonathan A. Bernstein, Asif Khan, Scott D. Nash, Juby A. Jacob‐Nara, Shahid Siddiqui, Paul J. Rowe, Yamo Deniz

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Type 2 Inflammation and Asthma in Children: A Narrative Review mā Nikolaos G. Papadopoulos, Leonard B Bacharier, Daniel J Jackson, A. Deschildre, Wanda Phipatanakul, Stanley J Szefler, Rebecca Gall, Olivier Ledanois, Juby A Jacob-Nara, Harry Sacks

I whakaputaina 2024

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Disease Burden and Unmet Need in Eosinophilic Esophagitis mā Albert J. Bredenoord, Kiran Patel, Alain Schoepfer, Evan S. Dellon, Mirna Chehade, Seema S. Aceves, Jonathan M. Spergel, Brad Shumel, Yamo Deniz, Paul J. Rowe, Juby A. Jacob‐Nara

I whakaputaina 2022

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINU... mā Claus Bachert, Asif Khan, Stella E. Lee, Claire Hopkins, Anju T. Peters, Wytske J. Fokkens, Amy Praestgaard, Amr Radwan, Scott D. Nash, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE) mā Jorge Máspero, Martti Antila, A. Deschildre, Leonard B. Bacharier, Arman Altincatal, Elizabeth Laws, Eric Mortensen, Amr Radwan, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study mā Alessandro Fiocchi, Wanda Phipatanakul, Robert S. Zeiger, Sandy Durrani, Jeremy Cole, Jérôme Msihid, Rebecca Gall, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin, Yi Zhang, Asif Khan

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline mā Arnaud Bourdin, J. Christian Virchow, Alberto Papi, Njira Lugogo, Philip G. Bardin, Martti Antila, David Halpin, Nadia Daizadeh, Michel Djandji, Benjamin Ortiz, Juby A. Jacob‐Nara, Rebecca Gall, Yamo Deniz, Paul J. Rowe

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study mā Jorge Máspero, Guido Cardona, Patricia Schonffeldt, Alberto Tolcachier, Sandra Nora González Díaz, Anahí Yáñez, Clóvis Eduardo Santos Galvão, Jérôme Msihid, Rebecca Gall, Shahid Siddiqui, Paul J. Rowe, Yamo Deniz, Juby A. Jacob‐Nara, Michel Djandji

I whakaputaina 2022

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study mā Leonard B. Bacharier, Theresa W. Guilbert, Constance H. Katelaris, A. Deschildre, Wanda Phipatanakul, Dongfang Liu, Arman Altincatal, Leda Mannent, Nikhil Amin, Elizabeth Laws, Bolanle Akinlade, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma mā Nikolaos G. Papadopoulos, Stanley J. Szefler, Leonard B. Bacharier, Jorge Máspero, Christian Domingo, Alessandro Fiocchi, Jason K. Lee, Nadia Daizadeh, David J. Lederer, Megan Hardin, Rebecca Gall, Michel Djandji, Shahid Siddiqui, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines mā Michael E. Wechsler, Adelmir Souza‐Machado, Christine Xu, Xuezhou Mao, Upender Kapoor, Faisal A. Khokhar, John T. O’Malley, Christopher D. Petro, Veronica Mas Casullo, Leda Mannent, Paul J. Rowe, Juby A. Jacob‐Nara, Marcella Ruddy, Elizabeth Laws, Lisa A. Purcell, Megan Hardin

I whakaputaina 2021

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis mā Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro, Parameswaran Nair, D. Staumont‐Sallé, Amr Radwan, Robert R. Johnson, Upender Kapoor, Faisal A. Khokhar, Nadia Daizadeh, Zhen Chen, Elizabeth Laws, Benjamin Ortiz, Juby A. Jacob‐Nara, Leda Mannent, Paul J. Rowe, Yamo Deniz

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma mā Ian Pavord, Klaus F. Rabe, Elliot Israel, Stanley J. Szefler, Guy Brusselle, Nami Pandit‐Abid, Arman Altincatal, Zhen Chen, Nikhil Amin, Asif Khan, David J. Lederer, Yi Zhang, Paul J. Rowe, Yamo Deniz, Amr Radwan, Juby A. Jacob‐Nara, William W. Busse

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction mā Nicola A. Hanania, Mario Castro, Eric D. Bateman, Ian Pavord, Alberto Papi, J. Mark FitzGerald, Jorge Máspero, Constance H. Katelaris, Dave Singh, Nadia Daizadeh, Arman Altincatal, Nami Pandit‐Abid, Xavier Soler, Shahid Siddiqui, Elizabeth Laws, Juby A. Jacob‐Nara, Paul J. Rowe, David J. Lederer, Megan Hardin, Yamo Deniz

I whakaputaina 2022

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma mā Daniel J. Jackson, Leonard B. Bacharier, Wanda Phipatanakul, Lawrence Sher, Christian Domingo, Nikolaos G. Papadopoulos, Brian D. Modena, Ning Li, Changming Xia, Mohamed Kamal, Myles Dillon, Kelley Wolfe, Rebecca Gall, Nikhil Amin, Leda Mannent, Elizabeth Laws, Paul J. Rowe, Juby A. Jacob‐Nara, Yamo Deniz, David J. Lederer, Megan Hardin, Christine Xu

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial mā Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira Lugogo, Christopher E. Brightling, Francisco Javier González‐Barcala, Arnaud Bourdin, Мykola Ostrovskyy, Maria Staevska, P I Chou, Liliana Duca, Ana Pereria, Charles Fogarty, Rufai Nadama, Mei Zhang, Amelie Rodrigues, Xavier Soler, Simona Pantelimon, Harry Sacks, Yamo Deniz, Paul Rowe, Lucía De Prado Gómez, Juby A. Jacob‐Nara

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: